+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Plasma Protein Therapeutics Market Research Report by Product, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

  • ID: 4968904
  • Report
  • July 2021
  • Region: Global
  • 184 pages
  • 360iResearch™
UP TO OFF
until Sep 30th 2021
The Global Plasma Protein Therapeutics Market will Grow to USD 42.65 Billion by 2026, at a CAGR of 10.46%

FEATURED COMPANIES

  • Access Plasma LLC
  • BPL Plasma Inc.
  • Csl Behring Llc
  • Grifols, S.A.
  • Kamada Pharmaceuticals.
  • Omega Laboratories Ltd
The Global Plasma Protein Therapeutics Market size was estimated at USD 23.47 Billion in 2020 and expected to reach USD 25.85 Billion in 2021, at a Compound Annual Growth Rate (CAGR) 10.46% to reach USD 42.65 Billion by 2026.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Plasma Protein Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the Plasma Protein Therapeutics Market was studied across Albumins, C1-esterase Inhibitors, Coagulation Factors, Hyperimmune Globulins, and Immunoglobulins.
  • Based on Application, the Plasma Protein Therapeutics Market was studied across Hereditary Angioedema, Idiopathic Thrombocytopenic Purpura, Primary Immunodeficiency Disorder, and Secondary Immunodeficiency.
  • Based on Region, the Plasma Protein Therapeutics Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Plasma Protein Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Plasma Protein Therapeutics Market, including Access Plasma LLC, Antigen Laboratories, Inc., B Positive Plasma LLC, Baxter, BioLife Plasma Services LP, Biotest AG, Blood and Plasma Research Inc., BPL Plasma Inc., Bracco Diagnostics, Inc, Canadian Plasma Resources, Cara Plasma s.r.o, Chengdu Institute of Biology, China Biologic Products Holdings, Inc., Csl Behring Llc, CSL Plasma, Europlasma GmbH, GCAM Inc., Grifols, S.A., Haema AG, Hemarus LLC, Immunotek Bio Centers LLC, Kamada Pharmaceuticals., KEDPlasma LLC, Kedrion SpA, Octapharma USA, Inc., Omega Laboratories Ltd, Plasmaspendedienst Graz, PlasmaVita, Prometic Plasma Resources, Reliance Life Sciences., Ruhr Plasma GmbH, Scantibodies Biologics, and Shire Plc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Plasma Protein Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Plasma Protein Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Plasma Protein Therapeutics Market?
4. What is the competitive strategic window for opportunities in the Global Plasma Protein Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the Global Plasma Protein Therapeutics Market?
6. What is the market share of the leading vendors in the Global Plasma Protein Therapeutics Market?
7. What modes and strategic moves are considered suitable for entering the Global Plasma Protein Therapeutics Market?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Access Plasma LLC
  • BPL Plasma Inc.
  • Csl Behring Llc
  • Grifols, S.A.
  • Kamada Pharmaceuticals.
  • Omega Laboratories Ltd
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. Application Outlook
3.5. Region Outlook
3.6. Competitor Outlook

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased prevalence and autoimmune and neurological diseases
5.1.1.2. Need for regular infusions or injections throughout the life of patient
5.1.1.3. Increased access and affordability of plasma protein therapies for patients
5.1.2. Restraints
5.1.2.1. Strict regulations pertaining to handling of plasma protein
5.1.3. Opportunities
5.1.3.1. Market amalgamation activity supporting research and development activity related to the plasma protein
5.1.3.2. Development of efficient protein plasma extraction/ manufacturing process
5.1.4. Challenges
5.1.4.1. Infectious disease transfer
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry

6. Plasma Protein Therapeutics Market, by Product
6.1. Introduction
6.2. Albumins
6.3. C1-esterase Inhibitors
6.4. Coagulation Factors
6.5. Hyperimmune Globulins
6.6. Immunoglobulins

7. Plasma Protein Therapeutics Market, by Application
7.1. Introduction
7.2. Hereditary Angioedema
7.3. Idiopathic Thrombocytopenic Purpura
7.4. Primary Immunodeficiency Disorder
7.5. Secondary Immunodeficiency

8. Americas Plasma Protein Therapeutics Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Plasma Protein Therapeutics Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Thailand

10. Europe, Middle East & Africa Plasma Protein Therapeutics Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Access Plasma LLC
12.2. Antigen Laboratories, Inc.
12.3. B Positive Plasma LLC
12.4. Baxter
12.5. BioLife Plasma Services LP
12.6. Biotest AG
12.7. Blood and Plasma Research Inc.
12.8. BPL Plasma Inc.
12.9. Bracco Diagnostics, Inc
12.10. Canadian Plasma Resources
12.11. Cara Plasma s.r.o
12.12. Chengdu Institute of Biology
12.13. China Biologic Products Holdings, Inc.
12.14. Csl Behring Llc
12.15. CSL Plasma
12.16. Europlasma GmbH
12.17. GCAM Inc.
12.18. Grifols, S.A.
12.19. Haema AG
12.20. Hemarus LLC
12.21. Immunotek Bio Centers LLC
12.22. Kamada Pharmaceuticals.
12.23. KEDPlasma LLC
12.24. Kedrion SpA
12.25. Octapharma USA, Inc.
12.26. Omega Laboratories Ltd
12.27. Plasmaspendedienst Graz
12.28. PlasmaVita
12.29. Prometic Plasma Resources
12.30. Reliance Life Sciences.
12.31. Ruhr Plasma GmbH
12.32. Scantibodies Biologics
12.33. Shire Plc.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2020 VS 2026 (USD BILLION)
FIGURE 2. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 (USD BILLION)
FIGURE 3. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2020 (USD BILLION)
FIGURE 4. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY REGION, 2020 (USD BILLION)
FIGURE 5. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 6. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: MARKET DYNAMICS
FIGURE 7. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 8. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
FIGURE 9. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD BILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2026
FIGURE 11. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMINS, 2018-2026 (USD BILLION)
FIGURE 12. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMINS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 13. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY C1-ESTERASE INHIBITORS, 2018-2026 (USD BILLION)
FIGURE 14. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY C1-ESTERASE INHIBITORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 15. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTORS, 2018-2026 (USD BILLION)
FIGURE 16. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTORS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 17. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULINS, 2018-2026 (USD BILLION)
FIGURE 18. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULINS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 19. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULINS, 2018-2026 (USD BILLION)
FIGURE 20. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 21. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 22. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD BILLION)
FIGURE 23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2026
FIGURE 24. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, 2018-2026 (USD BILLION)
FIGURE 25. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 26. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IDIOPATHIC THROMBOCYTOPENIC PURPURA, 2018-2026 (USD BILLION)
FIGURE 27. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IDIOPATHIC THROMBOCYTOPENIC PURPURA, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 28. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY DISORDER, 2018-2026 (USD BILLION)
FIGURE 29. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY DISORDER, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 30. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SECONDARY IMMUNODEFICIENCY, 2018-2026 (USD BILLION)
FIGURE 31. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SECONDARY IMMUNODEFICIENCY, BY REGION, 2020 VS 2026 (USD BILLION)
FIGURE 32. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 33. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 34. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 35. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 36. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 37. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 38. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 39. AUSTRALIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 40. CHINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 41. INDIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 42. INDONESIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 43. JAPAN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 44. MALAYSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 45. PHILIPPINES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 46. SINGAPORE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 47. SOUTH KOREA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 48. THAILAND PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 49. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 50. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 51. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 52. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 53. NETHERLANDS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 54. QATAR PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 55. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 56. SAUDI ARABIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 57. SOUTH AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 58. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 59. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 60. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
FIGURE 61. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: FPNV POSITIONING MATRIX
FIGURE 62. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 63. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET, BY TYPE

List of Tables
TABLE 1. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 4. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRODUCT, 2018-2026 (USD BILLION)
TABLE 5. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY ALBUMINS, BY REGION, 2018-2026 (USD BILLION)
TABLE 6. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY C1-ESTERASE INHIBITORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 7. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY COAGULATION FACTORS, BY REGION, 2018-2026 (USD BILLION)
TABLE 8. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HYPERIMMUNE GLOBULINS, BY REGION, 2018-2026 (USD BILLION)
TABLE 9. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IMMUNOGLOBULINS, BY REGION, 2018-2026 (USD BILLION)
TABLE 10. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY APPLICATION, 2018-2026 (USD BILLION)
TABLE 11. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY HEREDITARY ANGIOEDEMA, BY REGION, 2018-2026 (USD BILLION)
TABLE 12. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY IDIOPATHIC THROMBOCYTOPENIC PURPURA, BY REGION, 2018-2026 (USD BILLION)
TABLE 13. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY DISORDER, BY REGION, 2018-2026 (USD BILLION)
TABLE 14. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, BY SECONDARY IMMUNODEFICIENCY, BY REGION, 2018-2026 (USD BILLION)
TABLE 15. AMERICAS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 16. ARGENTINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 17. BRAZIL PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 18. CANADA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 19. MEXICO PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 20. UNITED STATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 21. ASIA-PACIFIC PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 22. AUSTRALIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 23. CHINA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 24. INDIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 25. INDONESIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 26. JAPAN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 27. MALAYSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 28. PHILIPPINES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 29. SINGAPORE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 30. SOUTH KOREA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 31. THAILAND PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 32. EUROPE, MIDDLE EAST & AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 33. FRANCE PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 34. GERMANY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 35. ITALY PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 36. NETHERLANDS PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 37. QATAR PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 38. RUSSIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 39. SAUDI ARABIA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 40. SOUTH AFRICA PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 41. SPAIN PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 42. UNITED ARAB EMIRATES PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 43. UNITED KINGDOM PLASMA PROTEIN THERAPEUTICS MARKET SIZE, 2018-2026 (USD BILLION)
TABLE 44. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: SCORES
TABLE 45. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: BUSINESS STRATEGY
TABLE 46. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: PRODUCT SATISFACTION
TABLE 47. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: RANKING
TABLE 48. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 49. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: MERGER & ACQUISITION
TABLE 50. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 51. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 52. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: INVESTMENT & FUNDING
TABLE 53. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 54. GLOBAL PLASMA PROTEIN THERAPEUTICS MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Access Plasma LLC
  • Antigen Laboratories, Inc.
  • B Positive Plasma LLC
  • Baxter
  • BioLife Plasma Services LP
  • Biotest AG
  • Blood and Plasma Research Inc.
  • BPL Plasma Inc.
  • Bracco Diagnostics, Inc
  • Canadian Plasma Resources
  • Cara Plasma s.r.o
  • Chengdu Institute of Biology
  • China Biologic Products Holdings, Inc.
  • Csl Behring Llc
  • CSL Plasma
  • Europlasma GmbH
  • GCAM Inc.
  • Grifols, S.A.
  • Haema AG
  • Hemarus LLC
  • Immunotek Bio Centers LLC
  • Kamada Pharmaceuticals.
  • KEDPlasma LLC
  • Kedrion SpA
  • Octapharma USA, Inc.
  • Omega Laboratories Ltd
  • Plasmaspendedienst Graz
  • PlasmaVita
  • Prometic Plasma Resources
  • Reliance Life Sciences.
  • Ruhr Plasma GmbH
  • Scantibodies Biologics
  • Shire Plc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll